Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets
Pharmaceutical Deal market report of 70+ pages covers Pharmaceutical Deal analysis, Pharmaceutical Deal market size with focus on trends, developments, mergers and acquisitions, Pharmaceutical Deal market share analysis, Pharmaceutical Deal companies both
(EMAILWIRE.COM, May 04, 2018 ) MarketIntelReports, Singapore, April 27, 2018.
MarketIntelReports : A global report titled Pharmaceutical Deal Market has been introduced into our library of 2.5 million reports.
Title of the report: Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Year: 2018
Details in the report: This is a 78 page report which includes demand analysis by country, application, manufacturers, product categories. Report also includes key developments, market share analysis, market sizing by country, market trends/ future trends, strategic initiatives, key product launches as well.
About the market report:
Although the pharmaceutical market is continuing to witness global growth, pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market, such as increasing costs of production and R&D, shifts in patent laws, and challenges in the economy. Companies are considering various strategies to overcome these challenges, with deal making being foremost among these as a means of boosting revenues over a short period of time.
Small companies that primarily carry out early-stage research, development and production activities are entering into agreements with key industry leaders to out-license the rights to their products, utilizing the strengths of the larger companies in terms of commercialization expertise, manufacturing, distribution and marketing capabilities and global presence. Additionally, many companies have successfully implemented deal-making strategies to secure extended protection for their products from generic competitors. Deal activity can help pharma companies to enhance their research and regulatory approaches, and can aid portfolio expansion and diversification, geographic expansion, entry into niche markets, commercialization, and sales.
To access the full table of contents of the report click below:
Link to the table of contents:https://www.marketintelreports.com/report/cbr0001/pharmaceutical-deal-trends-2017-factbook-partnerships-and-acquisitions-shift-focus-towards-early-stage-development-emerging-markets-and-biologics
Scope of the Report:
- What deal making strategies have been used in recent years to boost R&D productivity and allow the successful commercialization of pharmaceutical products?
- In which geographical markets and disease areas has deal activity been focused since 2010?
- At which stage of development did deals most frequently occur, and attract the highest value?
- How have pharma companies been using deal making to strengthen their product portfolio and bottom line?
- What are the most significant Mergers and Acquisitions (M&As), licensing deals and partnership deals to have been announced since 2016?
- Who are the major players in pharmaceutical deal making, and what has been their recent and key deal activity?
To find out more of the report or request some customization :
Link to the Inquiry before purchase:https://www.marketintelreports.com/inquiry-before-buying.php?id=cbr0001
Table of Contents-Key Points Covered – Partial paste
Introduction
Overview
Factors Promoting Deal Activity
Key Strategies Implemented in Deals
Geographical Expansion
Portfolio Enhancement
Market Consolidation
………….
Overview of Pharmaceutical Deals from 2010 to 2016
Pharmaceutical Deals by Value and Year
Number of Deals by Region/Country
Number of Deals by Prominent Therapy Area
Number of Deals by Stage of Development
Continued…..
Complete Report Details @ https://www.marketintelreports.com/report/cbr0001/pharmaceutical-deal-trends-2017-factbook-partnerships-and-acquisitions-shift-focus-towards-early-stage-development-emerging-markets-and-biologics
Contact us for any queries on the report:
Lakshmi
Sales Manager
Email : sales@marketintelreports.com
www.marketintelreports.com
Contact Sales: 1-302-261-5343
About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
MarketIntelReports : A global report titled Pharmaceutical Deal Market has been introduced into our library of 2.5 million reports.
Title of the report: Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Year: 2018
Details in the report: This is a 78 page report which includes demand analysis by country, application, manufacturers, product categories. Report also includes key developments, market share analysis, market sizing by country, market trends/ future trends, strategic initiatives, key product launches as well.
About the market report:
Although the pharmaceutical market is continuing to witness global growth, pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market, such as increasing costs of production and R&D, shifts in patent laws, and challenges in the economy. Companies are considering various strategies to overcome these challenges, with deal making being foremost among these as a means of boosting revenues over a short period of time.
Small companies that primarily carry out early-stage research, development and production activities are entering into agreements with key industry leaders to out-license the rights to their products, utilizing the strengths of the larger companies in terms of commercialization expertise, manufacturing, distribution and marketing capabilities and global presence. Additionally, many companies have successfully implemented deal-making strategies to secure extended protection for their products from generic competitors. Deal activity can help pharma companies to enhance their research and regulatory approaches, and can aid portfolio expansion and diversification, geographic expansion, entry into niche markets, commercialization, and sales.
To access the full table of contents of the report click below:
Link to the table of contents:https://www.marketintelreports.com/report/cbr0001/pharmaceutical-deal-trends-2017-factbook-partnerships-and-acquisitions-shift-focus-towards-early-stage-development-emerging-markets-and-biologics
Scope of the Report:
- What deal making strategies have been used in recent years to boost R&D productivity and allow the successful commercialization of pharmaceutical products?
- In which geographical markets and disease areas has deal activity been focused since 2010?
- At which stage of development did deals most frequently occur, and attract the highest value?
- How have pharma companies been using deal making to strengthen their product portfolio and bottom line?
- What are the most significant Mergers and Acquisitions (M&As), licensing deals and partnership deals to have been announced since 2016?
- Who are the major players in pharmaceutical deal making, and what has been their recent and key deal activity?
To find out more of the report or request some customization :
Link to the Inquiry before purchase:https://www.marketintelreports.com/inquiry-before-buying.php?id=cbr0001
Table of Contents-Key Points Covered – Partial paste
Introduction
Overview
Factors Promoting Deal Activity
Key Strategies Implemented in Deals
Geographical Expansion
Portfolio Enhancement
Market Consolidation
………….
Overview of Pharmaceutical Deals from 2010 to 2016
Pharmaceutical Deals by Value and Year
Number of Deals by Region/Country
Number of Deals by Prominent Therapy Area
Number of Deals by Stage of Development
Continued…..
Complete Report Details @ https://www.marketintelreports.com/report/cbr0001/pharmaceutical-deal-trends-2017-factbook-partnerships-and-acquisitions-shift-focus-towards-early-stage-development-emerging-markets-and-biologics
Contact us for any queries on the report:
Lakshmi
Sales Manager
Email : sales@marketintelreports.com
www.marketintelreports.com
Contact Sales: 1-302-261-5343
About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Contact Information:
MarketIntelReports
Lakshmi
Tel: 1-302-261-5343
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketIntelReports
Lakshmi
Tel: 1-302-261-5343
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results